There is no single “one size fits all” cell-based assay however 3D cell cultures have been shown to be more physiologically relevant in oncology, immune oncology and other fields.
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
During this webinar, Dr. Suzanne Riches highlights a variety of approaches for conducting virology assays in a high-throughput format.
We are delighted to announce that, thanks to our loyal customers, the Cellaca™ MX High-throughput Cell Counter has been nominated in the Life Sciences category.
It is important to select the most accurate cell counting method that is fit-for-purpose where cell number and viability significantly affect treatment efficacy.
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.
Immunotherapy is a diverse and broad catch-all for any treatments and therapies that utilize the patient’s own immune response to mount a defense.
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
